Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Amoxicillin (as amoxicillin sodium) 1 g powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Amoxicillin (as amoxicillin sodium) 1 g powder for solution for injection vial |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
Mitomycin 20 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Mitomycin 20 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Fludarabine phosphate 50 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Fludarabine phosphate 50 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Mycophenolate mofetil (as mycophenolate mofetil hydrochloride) 500 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely indometacin 5 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely idarubicin hydrochloride 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely idarubicin hydrochloride 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Chlorpromazine hydrochloride 5 mg/mL oral solution |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Ifosfamide 1 g powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Ifosfamide 1 g powder for solution for injection vial |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
Ifosfamide 1 g powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
omeprazol 40 mg pulver til injektionsvæske, opløsning, hætteglas |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
omeprazol 40 mg pulver til injektionsvæske, opløsning, hætteglas |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Lanreotide (as lanreotide acetate) 30 mg powder for suspension for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Lanreotide (as lanreotide acetate) 30 mg powder for suspension for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely idarubicin hydrochloride 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely idarubicin hydrochloride 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Ifosfamide 2 g powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Ifosfamide 2 g powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely lenograstim 13.4 million unit/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely clonazepam 100 microgram/1 milliliter conventional release oral solution (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely remifentanil (as remifentanil hydrochloride) 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely remifentanil (as remifentanil hydrochloride) 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Liothyronine sodium 20 microgram powder for solution for injection ampule |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Liothyronine sodium 20 microgram powder for solution for injection ampule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely thiopental sodium 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely thiopental sodium 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely melphalan (as melphalan hydrochloride) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely melphalan (as melphalan hydrochloride) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
natriumnitroprussid 50 mg pulver til injektionsvæske, opløsning, hætteglas |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
natriumnitroprussid 50 mg pulver til injektionsvæske, opløsning, hætteglas |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely octreotide (as octreotide acetate) 10 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely octreotide (as octreotide acetate) 10 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Leuprorelin acetate 11.25 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Leuprorelin acetate 11.25 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely cyanocobalamin 7 microgram/1 milliliter conventional release oral solution (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Leuprorelin acetate 3.75 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Leuprorelin acetate 3.75 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely vancomycin (as vancomycin hydrochloride) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely vancomycin (as vancomycin hydrochloride) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely vindesine sulfate 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely vindesine sulfate 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely omeprazole (as omeprazole sodium) 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely omeprazole (as omeprazole sodium) 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely porfimer sodium 75 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely porfimer sodium 75 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Palivizumab 50 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Palivizumab 50 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2b 100 microgram/1 vial powder for conventional release solution for injection |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2b 100 microgram/1 vial powder for conventional release solution for injection |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Treosulfan 5 g powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Treosulfan 5 g powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely nabumetone 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely vecuronium bromide 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely vecuronium bromide 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely flucloxacillin (as flucloxacillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely flucloxacillin (as flucloxacillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
meropenem 1 g pulver til injektionsvæske, opløsning, hætteglas |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
meropenem 1 g pulver til injektionsvæske, opløsning, hætteglas |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
meropenem 1 g pulver til injektionsvæske, opløsning, hætteglas |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely furosemide 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely micafungin (as micafungin sodium) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely micafungin (as micafungin sodium) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Vinblastine sulfate 10 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Vinblastine sulfate 10 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Sodium valproate 400 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Sodium valproate 400 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Flucloxacillin (as flucloxacillin sodium) 1 g powder for solution for injection vial |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
Flucloxacillin (as flucloxacillin sodium) 1 g powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Flucloxacillin (as flucloxacillin sodium) 1 g powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Prednisolone 3 mg/mL oral solution |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely secretin 16 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely secretin 16 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Pentamidine isetionate 300 mg powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Pentamidine isetionate 300 mg powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely rasburicase 1.5 milligram/1 vial powder for conventional release solution for injection |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely rasburicase 1.5 milligram/1 vial powder for conventional release solution for injection |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
Streptomycin (as streptomycin sulfate) 1 g powder for solution for injection vial |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
Streptomycin (as streptomycin sulfate) 1 g powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Streptomycin (as streptomycin sulfate) 1 g powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Vancomycin (as vancomycin hydrochloride) 1 g powder for solution for injection vial |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Vancomycin (as vancomycin hydrochloride) 1 g powder for solution for injection vial |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
Vancomycin (as vancomycin hydrochloride) 1 g powder for solution for injection vial |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely voriconazole 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Count of base of active ingredient |
False |
en |
Inferred relationship |
Some |
|
Product containing precisely voriconazole 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |